A leading provider of advanced magnetic detection technologies,
Metrasens has proudly announced about the recent grant for a new patent
by the US Patent and Trademark Office (USPTO) for further strengthening
of its patent portfolio. The newly granted patent revolves around the
protection of the technology proficient in decreasing alarm weakness in
the Ferromagnetic Detection Systems (FMDS) of Metrasens. Being used to
increase the safety of staff and patients in the MRI departments of
hospitals, Metrasens’ FMDS systems for MRI safety were invented by the
company’s founders and have been purchased by MRI departments in 36
countries since 2003, when they were first introduced globally.
By
obtaining its first patent before 2000 along with a total of 21
international patents till now, Metrasens at present has a considerable Intellectual Property
(IP) in the field of magnetic detection. Nevertheless, this family’s
patent protection granted in China is currently subject to a challenge
by Nanjing Cloud Magnet Electronic Technology Company Limited in the
China State Intellectual Property Office (SIPO). Metrasens is defending
itself against the plaintiff and its affiliate – Nanjing Haole
Technology Company Limited (NH) in the Nanjing Intermediate Court for
Copyright Infringement and in the Shanghai Intellectual Property Court
for Patent Infringement.
A decision announced by SIPO in regards to this case has proclaimed
that the office concludes the patent to be invalid because it lacks an
inventive step. It appears that Metrasens will robustly appeal to the
SIPO decision.
Metrasens with an intention to defend itself
claimed that previously, Nanjing Haole Technology Company Limited was a
distributor appointed to disseminate its Ferroguard FMDS products in
Southern China. Metrasens had terminated the relationship as it found
this group emerging and selling products that possessed very similar
technical features and functions to those for which Metrasens had
obtained patents. With the aid of Beijing Yihai (one of its
distributors), Metrasens has evolved as a leader in providing MRI safety
services and resolutions to hospitals throughout China. Metrasens also
has a Patent Application having further eight patents that reflect its investment to develop technology that helps in keeping the Chinese citizens safe.
Metrasens’
CEO and co-founder, Dr. Simon Goodyear, said that their close
connections with MRI system vendors and the Chinese radiology community
facilitated the fast and accelerating adoption of their Ferroguard
systems in China.They are proud that both the IP executives and the MRI
community value the benefits of their products, which are the result of
years of their experience in this field. The new patent will help them
in continuing to pursue their goals of safeguarding Metrasens’
intellectual property and businesses and of improving patient safety in
China.
For
view source: https://www.trademarkmaldives.com/blog/metrasens-global-mri-safety-business-obtains-another-patent/
Don’t forget to follow us on social media:
Facebook – https://www.facebook.com/trademarkmaldives/
Twitter – https://twitter.com/trademarkmaldiv
Pinterest – https://in.pinterest.com/trademarkmaldives/
No comments:
Post a Comment